| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |